The purpose of this study is to evaluate the efficacy and safety of standard-of-care chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite stable colorectal cancer.
- Investigator
- Mina Shenouda
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All